Pharmabiz1h
StarFish Medical expands local footprint to California by acquiring Omnica Corporation
StarFish Medical expands local footprint to California by acquiring Omnica Corporation: Toronto, Canada Wednesday, November 6, 2024, 09:00 Hrs [IST] StarFish Medical, a leading No ...
Pharmabiz2h
Indian pharma, medical practitioners & medical academia work to reduce burden of NCDs: Dr Sunil Chiplunkar
Indian pharma, medical practitioners & medical academia work to reduce burden of NCDs: Dr Sunil Chiplunkar: Nandita Vijayasimha, Bengaluru Wednesday, November 6, 2024, 08:00 Hrs [ ...
Pharmabiz2h
TN govt notifies launch of ‘Mudhalvar Marundhagam’, TNCDA asks govt to introduce scheme through their shops
Even as the government of Tamil Nadu is taking all steps to launch the subsidized generic pharmacy network scheme, ‘Mudhalvar Marundhagam’ (Chief Minister’s Pharmacy) on the day of Tamil New Year ...
Pharmabiz2h
DBT soon to begin research on consequences of viral infection on cardiovascular health & prevention strategies
DBT soon to begin research on consequences of viral infection on cardiovascular health & prevention strategies: Gireesh Babu, New Delhi Wednesday, November 6, 2024, 08:00 Hrs [IST ...
Pharmabiz2h
ICMR launches 'First in the World Challenge' to revolutionize biomedical science
ICMR launches 'First in the World Challenge' to revolutionize biomedical science: Shardul Nautiyal, Mumbai Wednesday, November 6, 2024, 08:00 Hrs [IST] In a move inspired by India ...
Pharmabiz2h
India amends norms for Shea Stearine exports and imports
The Directorate General of Foreign Trade (DGFT) has introduced modifications to the Standard Input Output Norm (SION) E-125, covering exports of Shea Stearine, under Paragraph 1.03 of the Foreign ...
Pharmabiz2h
A GAME CHANGING BIOE3 POLICY
The Union government has recently released the new BioE3 (Biotechnology for Economy, Environment and Employment) policy for fostering high performance biomanufacturing which is the ability to produce ...
Pharmabiz5h
HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA-editing HG202 for macular degeneration
HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...
Pharmabiz13h
Memo Therapeutics appoints Frits van Alphen, MD as chief development officer
Memo Therapeutics AG (MTx), a late-stage biotech company translating unique immune responses into superior medicines to treat ...
Pharmabiz16h
Health groups and patients calls for government interference to make rare disease drugs affordable
Health groups and patients calls for government interference to make rare disease drugs affordable: Our Bureau, New Delhi Tuesday, November 5, 2024, 18:10 Hrs [IST] Health groups ...
Pharmabiz16h
Diadem presents new findings on early Alzheimer’s disease detection using p53-specific antibody at CTAD 2024
Diadem presents new findings on early Alzheimer’s disease detection using p53-specific antibody at CTAD 2024: Milano, Italy Tuesday, November 5, 2024, 18:00 Hrs [IST] Diadem SpA ...
Pharmabiz17h
Epredia’s SlideMate Laser slide printer receives innovative technology designation from Vizient
Epredia’s SlideMate Laser slide printer receives innovative technology designation from Vizient: Portsmouth, New Hampshire Tuesday, November 5, 2024, 17:00 Hrs [IST] Epredia, a ...